Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 40301 - 40325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ferric ammonium citrate	Approved Withdrawn	HMOX1	3162	upregulated	[ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of HMOX1 mRNA	22q12.3	A22066
Ferric ammonium citrate	Approved Withdrawn	HSPA1L	3305	upregulated	[ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of HSPA1L mRNA	6p21.33	A22066
Ferric ammonium citrate	Approved Withdrawn	HSPA9	3313	upregulated	[ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of HSPA9 mRNA	5q31.2	A22066
Ferric ammonium citrate	Approved Withdrawn	MT2A	4502	upregulated	[ferric ammonium citrate results in decreased abundance of Iron] which results in increased expression of MT2A mRNA	16q13	A22066
Ferric ammonium citrate	Approved Withdrawn	PMP22	5376	upregulated	[ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of PMP22 mRNA	17p12	A22066
Ferric ammonium citrate	Approved Withdrawn	TFRC	7037	upregulated	[ferric ammonium citrate results in decreased abundance of Iron] which results in increased expression of TFRC mRNA	3q29	A22066
Ferric ammonium citrate	Approved Withdrawn	TFRC	7037	downregulated	ferric ammonium citrate results in decreased expression of TFRC mRNA	3q29	A22057
Fexofenadine	Approved Investigational	CCL17	6361	downregulated	fexofenadine results in decreased expression of CCL17 mRNA	16q21	A22621
Fexofenadine	Approved Investigational	CCL22	6367	downregulated	fexofenadine results in decreased expression of CCL22 mRNA	16q21	A22621
Finasteride	Approved Investigational	CRH	1392	upregulated	[Finasteride results in increased susceptibility to IL1B protein] which results in increased expression of CRH mRNA	8q13.1	A22622
Fingolimod	Approved Investigational	ABCA1	19	upregulated	[Fingolimod Hydrochloride results in increased abundance of 27-hydroxycholesterol] which results in increased expression of ABCA1 mRNA	9q31.1	A22623
Fingolimod	Approved Investigational	ABCA1	19	upregulated	Fingolimod Hydrochloride results in increased expression of ABCA1 mRNA	9q31.1	A22623
Fingolimod	Approved Investigational	CCNG2	901	upregulated	Fingolimod Hydrochloride results in increased expression of CCNG2 mRNA	4q21.1	A20727
Fingolimod	Approved Investigational	HMGCR	3156	upregulated	Fingolimod Hydrochloride results in increased expression of HMGCR mRNA	5q13.3	A20727
Fingolimod	Approved Investigational	HMGCS1	3157	upregulated	Fingolimod Hydrochloride results in increased expression of HMGCS1 mRNA	5p12	A20727
Fingolimod	Approved Investigational	IDI1	3422	upregulated	Fingolimod Hydrochloride results in increased expression of IDI1 mRNA	10p15.3	A20727
Fingolimod	Approved Investigational	KLHL24	54800	upregulated	Fingolimod Hydrochloride results in increased expression of KLHL24 mRNA	3q27.1	A20727
Fingolimod	Approved Investigational	PDCD4	27250	upregulated	Fingolimod Hydrochloride results in increased expression of PDCD4 mRNA	10q25.2	A20727
Fingolimod	Approved Investigational	SQLE	6713	upregulated	Fingolimod Hydrochloride results in increased expression of SQLE mRNA	8q24.13	A20727
Fingolimod	Approved Investigational	ZBED8	63920	upregulated	Fingolimod Hydrochloride results in increased expression of ZBED8 mRNA	5q33.3	A20727
Flavone	Approved Investigational	ABCG2	9429	upregulated	flavone results in increased expression of ABCG2 mRNA	4q22.1	A22624
Flavone	Approved Investigational	CCL2	6347	downregulated	flavone results in decreased expression of CCL2 mRNA	17q12	A22625
Flavone	Approved Investigational	CYP1A1	1543	upregulated	flavone results in increased expression of CYP1A1 mRNA	15q24.1	A22626
Flavone	Approved Investigational	CYP1B1	1545	upregulated	flavone results in increased expression of CYP1B1 mRNA	2p22.2	A22626
Flavone	Approved Investigational	PON1	5444	upregulated	flavone results in increased expression of PON1 mRNA	7q21.3	A22627

Displaying entries 40301 - 40325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability